[Naidheachdan New Tang Dynasty, àm Beijing, 25 Samhain, 2024]After learning that he was suffering frombreast cancerAfter that, CroatiaA virusScientist Beata Halassy decided to grow her own virus to fight the disease, a move that went against the grain of medicine but seemed to work.
Halasi’s dangerous act of self-medication at the University of Zagreb sparked a mix of controversy and respect among her colleagues, according to a November 8 news report in Nature.
Halasi began researching tumor spread after learning in 2020 that she still had a third recurrence after undergoing a mastectomy.A virusOncolytic virotherapy (OVT), as the name suggests, uses viruses to induceimmune responseto fight disease. Although this is not unique and has been approved for early stage metastatic melanoma, globally there is no government approval.breast cancerOVT treatment, which made the whole experiment dangerous for Halassi, her doctors and colleagues, and ultimately the academic journal in which her story would be told.
The pathologist asked a colleague to inject her with a drug commonly used in childhood vaccinesthe measles(measles) and vesicular stomatitis virus, both of which are known to affect the types of cells it wants to destroy and stimulate the immune response it needs. As the two-month trial progressed, the tumor moved and separated from her muscles and skin, making surgical removal easier. When the tumors were removed after removal, Halasi and her colleagues found that their risk paid off.
“The immune response is definitely stimulated,” the pathologist said.
This all happened in 2020, which means that Halasi has now been cancer free for 4 years, but she has had trouble sharing her research with the world.
A research paper raises controversy
After writing a thesis proposal about her experience and submitting it to a journal, the researcher was repeatedly rejected. She noted that most editors were reluctant to talk to the paper because they were concerned about the ethics of self-testing, particularly the fear that others with less experience might try similar practices. to him, with disastrous results.
In fact, Jacob Sherkow, a law and medicine researcher at the University of Illinois at Urbana-Champaign who was not involved in Halassi’s paper, told Nature that academic journals need to be more proactive in raising awareness. on the conflicting issues of achieving a balance between gaining knowledge through self-knowledge. testing and not promoting such testing as a first-choice treatment.
As an expert on self-testing techniques in the early days of the COVID-19 pandemic, Scherko said he believed Halassi’s study was “certainly ethical, but not a clear case.”
Finally, Hallasi’s paper found an opportunity to be published in the journal “Vaccine”.
Despite the difficulties in publication, the psychologist is proud of her experiments and the people who published them.
“Only a brave editor would publish this study,” Hallasi told Nature.
(Reprinted from The Epoch Times/Editor: Ye Ping)
URL of this article: https://www.ntdtv.com/b5/2024/11/25/a103932462.html
2024-11-25 17:09:00
#Scientists #successfully #cure #breast #cancer #injecting #viruses #bodies #Immune #response
Considering the ethical complexities highlighted in Beata Halasi’s case, should there be clearer guidelines established for the publication of research stemming from self-experimentation?
## Interview on Self-Treatment of Breast Cancer with Oncolytic Virotherapy
**Introduction**
Welcome to World Today News! Today, we’re discussing a groundbreaking and controversial case study published in the journal “Vaccine.” Joining us are Dr. Emily Carter, an oncologist specializing in breast cancer treatment, and Dr. Andrew Lee, a bioethicist with expertise in research ethics.
**Section 1: Understanding Oncolytic Virotherapy**
* **Interviewer:** Dr. Carter, could you explain oncolytic virotherapy (OVT) for our audience? What are its principles, and how does it differ from traditional cancer treatments?
* **Dr. Carter:**
* **Interviewer:** The article highlights the experimental nature of OVT, particularly for breast cancer. Can you elaborate on the current state of this treatment modality and its limitations?
* **Dr. Carter:**
**Section 2: Beata Halasi’s Case Study: A Daring Experiment**
* **Interviewer:** Dr. Lee, Beata Halasi’s decision to use OVT on herself raises significant ethical concerns. What are your initial thoughts on this approach, given the risks involved?
* **Dr. Lee:**
* **Interviewer:** Dr. Carter, how effective do you believe Halasi’s self-treatment was? What might have been the potential downsides of her approach?
* **Dr. Carter:**
**Section 3: Ethical Dilemmas and the Publication Process**
* **Interviewer:** Dr. Lee, the article mentions the challenges Halasi faced in getting her research published. How do you see this case impacting the ethical conversations around self-experimentation in research?
* **Dr. Lee:**
* **Interviewer:** Dr. Carter, as a medical professional, how do you balance the potential benefits of innovative treatments like OVT with the need for rigorous scientific rigor and patient safety?
* **Dr. Carter:**
**Section 4: Looking Forward: The Future of Personalized Medicine**
* **Interviewer:** Dr. Lee, this case raises questions about the future of personalized medicine and patient autonomy. Where do we draw the line between individual choice and responsible scientific practice?
* **Dr. Lee:**
* **Interviewer:** Dr. Carter, what are the key takeaways from Halasi’s story for the field of oncology and the development of future cancer treatments?
* **Dr. Carter:**
**Conclusion**
* **Interviewer:** Thank you both for this insightful discussion. Beata Halasi’s story is undoubtedly complex, forcing us to grapple with ethical dilemmas and the ever-evolving nature of medical science. As we move forward, it is crucial to continue the conversation about personalized medicine, patient autonomy, and the responsible pursuit of innovation.
